CML stem cells/progenitors showed increased expression and activation of aPKCι (Fig. 1a, b and Supplementary Figure 1C) as compared to healthy donor CD34+ cells. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.